Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes:A Randomized Controlled Trial, Multi-center Trial

NCT03797534 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT03797534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03797534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes:A Randomized Controlled Trial, Multi-center Trial
Lead sponsor
Fujian Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2019
Completion date
January 1, 2023
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart valve prosthesis